ENTX
Entera Bio (ENTX)
$04
About Entera Bio (ENTX)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Details
Daily high
$1.22
Daily low
$1.00
Price at open
$1.14
52 Week High
$3.22
52 Week Low
$1.00
Market cap
47.7M
Dividend yield
0.00%
Volume
356,052
Avg. volume
213,534
P/E ratio
-4.25
Entera Bio News
Details
Daily high
$1.22
Daily low
$1.00
Price at open
$1.14
52 Week High
$3.22
52 Week Low
$1.00
Market cap
47.7M
Dividend yield
0.00%
Volume
356,052
Avg. volume
213,534
P/E ratio
-4.25